Clinical trial
A Study of Intra-dermal Injection of Botulinum Toxin Type A for the Diabetic Neuropathic Foot Pain
NCT00336349 is registered in ClinicalTrials.gov with Taipei Medical University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Intra-dermal Injection of Botulinum Toxin Type A for the Diabetic Neuropathic Foot Pain
- Lead sponsor
- Taipei Medical University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2006
- Completion date
- December 31, 2007
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, neuropathic pain